CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY (ISSN 0390-6663) publishes
original work, preferably brief reports, in the fields of Gynecology,
Obstetrics, Fetal Medicine, Gynecological Endocrinology and related subjects.
(Fertility and Sterility, Menopause, Uro-gynecology, Ultrasound in Obstetrics
and Gynecology, Sexually Transmitted Diseases).The Journal is covered by INDEX
MEDICUS, MEDLINE, EMBASE/Excerpta Medica.
CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY is issued every three
months in one volume per year by IROG CANADA Inc. Montréal. Printed in Italy by
"La Garangola", Tipografia Editrice - Via E. Dalla Costa, 6 -35129 Padova
Clinical and Experimental Obstetrics and
CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY (ISSN 0390-6663) publishes
original peer-reviewed work, preferably brief reports, in the fields of
Gynecology, Obstetrics, Fetal Medicine, Gynecological Endocrinology, Fertility
and Sterility, Menopause, Uro-gynecology, Ultrasound diagnosis in Obstetrics
and Gynecology, Sexually transmitted diseases and related topics. It is indexed
in INDEX MEDICUS, MEDLINE, EMBASE/ Excerpta Medica.
AIMS AND SCOPE
Since its inception, the CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY
Journal has had the primary aim to assemble and diffuse scientific
researches, particularly original researches, contributions, reviews, and
proceedings of meetings in every field of the Discipline.
Today its large diffusion all over the world allows us to collect high quality
papers and clinical reports on many interesting studies from every country,
even from developing countries. This is the target goal of the Journal –
aiming at the diffusion of knowledge and advances in female genital diseases.
This publication tries to cover all aspects of obstetrics and gynecology in an
interdisciplinary approach among gynecologists, epidemiologists, pathologists,
oncologists, radiologists, microbiologists, surgeons, urologists,
neonatologists, genetists and so on.
The first target goal of the Journal is to publish high quality papers
in the shortest time possible. Research papers, editorial
reviews, case reports, technical notes, book reviews and letters to the Editor
ANNOUNCEMENTS regarding meetings,
postgraduate courses and symposia will be accepted 6 months before publication
and will be published free of charge.
BOOK SAMPLES for review should be sent to the
Editorial offices in Montréal or in Padova.
COPYRIGHT: the Journal has been registered with the
Copyright Clearance Center, Inc. Reproductions are not allowed without the
written consent of the Publisher. All photocopy fees should be paid to the
Copyright Clearance Center, Inc., 21 Congress Street, Salem, MA 01970, USA
stating the ISSN number, the volume and the first and last page numbers of each
ADVERTISING INFORMATION: advertising orders and
inquiries may be sent to: I.R.O.G. CANADA Inc., Publisher, 4900 Côte St.
Luc, Apt. 212, Montréal (Quebec) Canada H3W 2HS, Tél.
514.4893242-4893640 - Fax 514.4854513 - E-mail:
email@example.com - www.irog.net
RESPONSIBILITY: although every effort is made by the
editorial staff and the printer to eliminate misleading or inaccurate
information, the publisher accepts no responsibility for the consequences of
faultful or incorrect information. The authors recognize that the editor and
publisher have no responsibility and are indemnified against any liability or
claim that may result from the publication of misleading or incorrect data.
The Journal is issued every three months (January, April, July and October);
one volume per year. Subscriptions start from January and are automatically
renewed if not cancelled by the end of September.
Subscriptions include four issues per year plus supplements and monographs and
all official communications of Meetings, Courses, Symposia and all scientific
activities in the fields of Obstetrics and Gynecology and related
Subscriptions are entered with prepayment only. The
annual subscription is $280 US for Institutions and $170 US for Individuals all
over the world. For air mail add $20. Single copies prepaid cost $75.00 US.
Send subscription requests with cheque or credit card payment (Amex - Visa -
Diners - Master Card) to I.R.O.G. CANADA Inc., 4900 Côte St. Luc, Apt.
212, Montréal, Québec H3W 2H3, Canada. Only US Funds are
Claims for missing issues can be honored up to six
months. Changes of address: allow six weeks for all
changes to become effective. All communications should include both old and new
addresses (with postal codes) - better if accompanied by a mailing label from a
recent issue and should be sent to the printer La Garangola, Via E. Dalla
Costa, 6 - 35129 Padova (Italy) - also by Tel. +39.049.8075557, Fax
+39.049.7806580. Claims should be made within six months of publication date.
Duplicate copies will not be sent to replace those undelivered through failure
to notify of change of address.
Single copies and back issue and volume information is
available from the printer La Garangola, Padua, Tel. +39.049.8075557, Fax
+39.049.7806580. Certain back issues may only be available as photocopies of
All other business correspondence including orders for offprints and
advertising space and any communication and requests should be addressed to
I.R.O.G. CANADA Inc., 4900 Côte St. Luc, Apt. 212, MONTRÉAL,
QUÉBEC H3W 2H3 (Canada), Tel. (514) 4893242, fax (514) 4854513.
IN ALL LEGAL MATTERS THE COURT OF MONTREAL IS COMPETENT.
Instructions to Authors
SUBMISSION OF MANUSCRIPTS
Papers should be submitted to A. ONNIS Editor-in-Chief of the EUROPEAN JOURNAL
OF GYNAECOLOGICAL ONCOLOGY, 4900 Côte St. Luc, Apt. 212 MONTREAL, QUÉBEC H3W
2H3 (Canada) - Tel. +514-4893242 - Fax +514-4854513, or Galleria Sto-rione 2/A
- 35123 PADOVA (Italy) - Fax +39-049-8752018.
Editorial articles for publication in the "Distinguished Expert Series" should
be submitted to P. Bösze, Editor-in-Chief of this section, Department of
Gynecology, Saint Stephan Hospital, 1096 Budapest, Nagyvárad tér 1, Telephone
(36-1) 275 2172, Fax (36-1)
275 2172, E-mail: firstname.lastname@example.org
When a manuscript is submitted, an acknowledgement card is sent to the
corresponding author within two or three weeks.
Submitted papers are reviewed by the Editor-in-Chief and his Peer Referees.
Authors may be required to modify the manuscript according to the reviewers'
Manuscripts accepted for publication will be copyedited by the editorial staff
for typographical and grammatical mistakes and to guarantee clarity and
Publication time will be the shortest possible based on
scientific and publishing needs. Manuscripts submitted for publi-cation
cannot be returned.
Published papers will become property of the Journal and copyrighted under
I.R.O.G. CANADA Inc.
After six months no grievances will be accepted regarding published articles.
All statements are the responsibility of the authors. Product dosages,
indications and methods referred to in the papers reflect the author's
experience. No responsibility is assumed by the Editor-in-Chief or the
Publisher for any damage from use of any products, operation methods or
instructions contained in the published materials.
Trade names, trademarks, etc. are protected by the law and regulations. The
Editor-in-Chief and the Publisher cannot accept any legal responsibility for
any errors or omissions that may be made in press, particularly for information
about drug dosage and appli-cation thereof contained in the Journal. Consult
the prescribing information before administering any drug.
The Journal follows the "Uniform requirements for manuscripts submitted to
biomedical journals" published in the New England Journal of Medicine 1991,
324, 424-8 and in the British Medical Journal 1991, 302.
Three manuscripts, typed and double spaced should be submitted
with an electronic disk, formatted in Word for Macintosh or Windows, version
6.0. Manuscripts without an electronic disk will not be accepted.
A cover letter signed by all authors must state that all authors who have
participated in the work take responsibility for the manuscript which has never
been pub lished or submitted for publication elsewhere. Without a
cover letter the publication will not be possible. Name, address and phone/fax
numbers of the Corresponding Author, responsible for revision and approval of
the proofs, should be indicated. Full-length articles should not exceed 8
printed pages including tables and references.
After the title page (full title and names of authors,
institutions, eventual acknowledgement for financial support, running title of
no more than 60 characters or spaces), original works should be arranged in the
conventional order: Summary (purpose of investiga-tion, methods, results,
conclusion - about 150 words), Key words, Content (a 20-word
summary), Introduction, Materials and Methods, Results, Discussion,
Conclusion, Acknowledgement (if any), References, Tables, Legends.
Authors should supply a complete address for reprint requests.
In the text only standard abbreviations can be used and must be avoided in the
title. The full term for which an abbreviation stands should precede its first
use in the summary and text unless it is a standard unit of measurement.
Authors must give their complete professional identifications
and affiliations, including all academic titles and positions.
Letters to the editor should be brief (500 words or less) and
offer objective, constructive and educational criticism of published material.
The editor reserves the right to publish.
Figures: Two original copies (not negatives) of each figure
are requested. Each figure should have a label on the back indicating its
number, author's name and top of the figure. Do not write on the back of the
figures and do not mount them on cardboard. If sending colour pictures
advise if they must be printed in colour or black and white (colour costs ten
Legends should be typed on a separate page with Arabic
numerals corresponding to the illustrations.
Tables should be titled, typed in double space on separate
pages and numbered in Arabic numerals in the order of their first cita-tion
in the text. Do not use internal rules. Only standard, universally understood
abbreviations should be used.
References should be numbered consecutively in the order in which they are
first mentioned in the text. Identify references in the text,
tables, and legends by Arabic numerals in parentheses.
Use the style of the examples below, which are based with slight modifications
on the format used by the U.S. National Library of Medicine in Index Medicus.
The titles of journals should be abbreviated according to the style used in
References must be verified by the Author(s) against the original documents.
Examples of correct forms of references are given below:
Articles in Journals: Authors' surname and initials (if more
than six names, give six followed by "et al."), Title, Abbreviated Journal
Title, Year of Publication, Volume, Issue and first page.
Books: Authors' surname and initials, title of the book and
title of chapter, in: Title, Editor(s), Place, Publisher, Year, Page.
Acknowledgments will be limited to appropriate professionals who
were contributors to the paper.
PROOFS revised by the editorial staff will be sent
to the corresponding author and should be checked and returned within ten days.
The corresponding author is responsible for detecting typesetting errors. After
this deadline the proofs will be considered approved. Only essential
corrections should be made; extensive changes will be charged to the authors.
The Journal has no commercial advertisements.
Authors will be expected to contribute to the printing expenses, tables,
figures and postage. For every published article a copy of the
Journal will be provided free of charge. Only payments in US dollars will
be accepted. No bank transfers.
Reprints should be requested with the form enclosed with the
acceptance letter. No free reprints will be supplied.
© By I.R.O.G. CANADA INC. - Publisher - Editorial office 4900
Côte St. Luc - Apt. 212 - Montréal Québec H3W 2H3 (Canada) - Tel. (514)
4893242-4893640 -Fax (514) 4854513 - Printed in Italy by "La Garangola" - Via
E. Dalla Costa, 6 - 35129 Padua (Italy) - Responsible Director: Prof. Antonio
Onnis M.D. - Authorization of Padua's Court n. 633 - 28-6-1979
Clinical and Experimental Obstetrics & Gynecology - Vol. XXXVII, no. 2, 2010
|A practical approach to the prevention of miscarriage: part 3 – passive immunotherapy
|J.H. Check - Camden, NJ (USA)
There is controversy over the efficacy of passive immunotherapy to prevent miscarriage, but there are some data that are
encouraging if the passive immunotherapy is properly given with the right brand and timing.
|Advantages of using a lower vs higher dosage of gonadotropins for follicular maturation including cycles
of in vitro fertilization-embryo transfer
|J.H. Check - Camden, NJ (USA)
The use of a lower dosage of exogenous FSH for follicular stimulation can not only save money but may result in higher
pregnancy rates compared to higher dosage regimens.
|The slow levonorgestrel-releasing intrauterine system (LNG-IUS) 20 mcg/day: a literature review
|N. Salakos, A. Koumousidis, C. Iavazzo, G. Paltoglou, K. Bakalianou, O. Gregoriou - Athens, GREECE
A review of indications, complications and contraindications of the levonorgestrel-releasing intrauterine system was performed.
|Reproductive Biology Section
|A novel method to assess the effect of uterine senescence by comparing pregnancy outcome in younger
donors vs older recipients who are sharing a common pool of oocytes
|J.H. Check, B. Katsoff, T. Jamison, J.K. Choe, D. Brasile, J. Amui - Camden, NJ (USA)
The evaluation of pregnancy and implantation rates aftr transfer of fresh or frozen embryos in younger infertile egg donors vs
older recipients confirmed that the uterus from a woman of advanced reproductive age does not impair embryo implantation.
|Cryopreservation of blastocysts using a modification of a simplified freezing protocol with a one step
removal of cryoprotectant successfully used previously to freeze 2 pronuclear or multi-cell embryos
|D. Summers-Chase, J.H. Check, D. Horwath, W. Yuan, K. Swenson, M. Press - Camden, NJ (USA)
A modification of a simplified freezing protocol usd for 2 pronuclear and multi-cell embryos has resulted in a successful cryopreservation
technique for blastocysts.
|Serum retinol-binding protein-4 levels in polycystic ovary syndrome patients undergoing controlled
ovarian hyperstimulation for in-vitro fertilization cycle
|R. Orvieto, V. Shuhat, G. Liberty, R. Homburg, E.Y. Anteby, R. Nahum, J. Rabinson, S. Meltcer - Beer
PCOS patients demonstrated a decrease in serum RBP-4 during COH with no correlation to IVF treatment variables or pregnancy
|A comparison of pregnancy rates following fresh and frozen embryo transfer according to the use of
leuprolide acetate vs ganirelix vs cetrorelix
|J.H. Check, C. Wilson, J.K. Choe, J. Amui, B. Katsoff - Camden, NJ (USA)
A retrospective review found that the gonadotropin releasing hormone (GnRH) agonist leuprolide did not result in higher
implantation rates than the GnRH antagonist cetrorelix but both were superior to ganirelix.
|The effect of endometriosis on pregnancy outcome following in vitro fertilization-embryo transfer (IVFET)
in women with decreased egg reserve
|J.H. Check, J.R. Liss, J.W. Krotec, J.K. Choe, D. Brasile - Camden, NJ (USA)
The presence of endometriosis did not impair live delivered pregnancy rates following fresh or frozen embryo transfers in
women with diminished egg reserve.
|Association of the change in serum estradiol (E2) levels from the day of to the day after human chorionic
gonadotropin (hCG) injection and pregnancy outcome following in vitro fertilization-embryo transfer
(IVF-ET) in less than average responders
|J.H Check, J.K. Choe, J. Amui, D. Brasile - Camden, NJ (USA)
A drop in serum estradiol in a group of women who were less than average responders was not associated with a lower
chance of conception following in vitro fertilization-embryo transfer.
|Effects of tamoxifen on tissue nitrite/nitrate levels and plasma lipid peroxidation in female rats
|M. Gharehbagni, F. Sendag, F. Akercan, B. Zeybek, E. Sezer, M.C. Terek, N. Karadadas - Izmir, TURKEY
The effects of tamoxifen on lipid peroxidation and oxidant-antioxidant balance were investigated in an animal model.
|Successful treatment of a female with chronic pseudo-intestinal obstruction with sympathomimetic
amines and thyroid hormone replacement
|J.H. Check, R. Cohen - Camden, NJ (USA)
Another way that idiopathic orthostatic edema may present is with classic symptoms and signs of chronic pseudointestinal
obstruction, and similar to other associated pain syndromes, the condition responds to sympathomimetic amine treatment.
|Emergency obstetric hysterectomy at two tertiary centers: a clinical analysis of 11 years experience
|M. Varras, Ch. Akrivis, Ch. Plis, G. Tsoukalos - Ioannina, GREECE
The incidence, indications and maternal mortality of emergency obstetric hysterectomies to control major postpartum hemorrhage
after delivery following a pregnancy of at least 24 weeks’ gestation, regardless of the mode of delivery, at two tertiary
Greek hospitals are presented.
|Comparision of reproductive outcome of the women with hypogonadotropic hypogonadism and tubal
|G. Yildirim, C. Ficicioglu, R. Attar, O. Akcin, N. Tecellioglu - Istanbul, TURKEY
The outcome of women with hypogonadotropic hypogonadism undergoing assisted reproductive treatment are comparable to
women with tubal factor infertility.
|Effect of long-time administration of tibolone on vaginal cytology of castrated rats
H.N. Henriques, A.C. Bergmann de Carvalho, J.A.S. Pantaleão, M.A. Guzmán-Silva - Niteroi, RJ BRAZIL
Tibolone administered at high-dose and long-term has estrogenic effects in vaginal epithelium evident after one dose, without
changes over time.
|Vaginal fluid pH, cervicovaginitis and cervical length in pregnancy
|F. Sendag, M. Kazandi, F. Akercan, A.C. Kazandi, N. Karadadas, S. Sagol - Irbid, JORDAN
Elevated vaginal fluid pH in women at 16-22 weeks of gestation seems to be associated with decreased cervical length and
increased risk of preterm delivery.
|Perineal ultrasound evaluation of urethral mobility after the TVT-O procedure
|L. Di Pietto, C. Scaffa, A. Lambiase, M. Torella, C. Sciorio, E. Dato, A. Nocerino, M.L. Di Petrillo, R.
Fusco, M. Rotondi, E.M. Messalli, N. Colacurci - Naples, ITALY
By means of perineal ultrasound the study evaluates urethral mobility in urinary stress incontinence before and after transobturator
tension-free vaginal tape surgery.
|Is placebo as effective as estrogen regimens on vasomotor symptoms in women with surgical menopause?
|H. Hassa, H.M. Tanir, T. Oge - Agri, TURKEY
Oral and transdermal forms of estrogen and placebo improved total Greene Climacteric Scale scores in women with surgical
|Tubal ectopic pregnancy in the north of Jordan: presentation and management
|B. Obeidat, F. Zayed, Z. Amarin, N. Obeidat, M.F. El-Jallad - Irbid, JORDAN
A retrospective study of the approach to the management tubal ectopic pregnancy in the north of Jordan.
|Umbilical cord prolapse in the southeast region of Turkey: evaluation of 79 cases
|M. Erdemoglu, A. Kale, U. Kuyumcuoglu, N. Akdeniz, A.I. Güzel - Diyarbakir, TURKEY
Fetal weight ≤ 2500 and abnormal fetal presentation is associated with increased risk of umbilical cord prolapse. Cesarean section
decreases the risk of perinatal mortality.
|Adolescent pregnancies and obstetric outcomes in Southeast Turkey: data from two regional centers
|D.C. Arıkan, M. Kaplanog˘lu, H. Kıran, A. Özer, A. Cos¸kun, E. Turgut - Istanbul, TURKEY
The incidence of adolescent pregnancy is still high in Turkey. Preterm labor, intrauterine growth retardation, and stillbirth were
significantly higher in pregnant adolescents.
|Pregnancy-related acute renal failure in the southeast region of Turkey: analysis of 75 cases
|M. Erdemog˘lu, U. Kuyumcuog˘lu, A. Kale, N. Akdeniz - Diyarbakir, TURKEY
A case series of 75 patients affected by acute renal failure related with pregnancy in a limited region of Turkey is reported.
|An analysis of hysteroscopy experience over a seven-year period
|E. Ozturk, M.G. Ugur, O. Balat, I. Kutlar, E. Dikensoy, B. Cebesoy - Gaziantep, TURKEY
Analysis of hysteroscopy experience indicates that this method is safe and useful for various gynecological disorders.
|Is insulin-dependent diabetes and obesity a predisposition for endometrial and pancreatic carcinoma?
|M. Gojnic, V. Dugalic, M. Brankovic, I. Stojanovic, M. Acimovic, B. Vasiljevic - Belgrade, SERBIA
The same risk factors for endometrial adenocarcinoma may also apply for pancreatic adenocarcinoma.
|Peripartum cardiomyopathy and Klippel-Trenaunay syndrome
|G. Carta, V. De Lellis, M. Di Nicola, D. Kaliakoudas - L’Aquila, ITALY
This study illustrates the correlation between the KTS and PPCM in women with twin pregnancies.
|Novel therapeutic strategy for uterine arteriovenous fistulas: case report
|R. Kizaki, J. Fujimoto, E. Sato, T. Tamaya - Gifu City, JAPAN
Precise evaluation with color Doppler, CT and angiography led to an adequate therapeutic strategy for uterine arteriovenous fistulas.